About 500 reports

  • VII. LYMPHOMA
  • Lymphoma Treatment Drugs Markets in China

Cytotoxic antibiotics and related drugs is one important Lymphoma Treatment Drugs in China.

  • Lymphoma
  • China
  • Shandong Luoxin Pharmacy Stock Co., Ltd.
  • Shenzhen Main Luck Pharmaceuticals Inc.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • LYMPHOMA TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • LYMPHOMA TREATMENT DRUGS INDUSTRY ASSESSMENTS

Cytotoxic antibiotics and related drugs is one important Lymphoma Treatment Drugs in China.

  • Lymphoma
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Pfizer Inc.
  • Shandong Luoxin Pharmacy Stock Co., Ltd.

The 2021-2026 World Outlook for Lymphoma Therapeutics ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cancer
  • Lymphoma
  • Pathology
  • World
  • Demand

You can request one free hour of our analyst’s time when you purchase this market report.

  • Lymphoma
  • Therapy
  • World
  • Market Size

Hoffmann-La Roche • Merck Sharp & Dohme • Novartis • Spectrum Pharmaceuticals About Burkitt Lymphoma Burkitt Lymphoma is one of the rare types of B-cell non-Hodgkin’s lymphoma.

  • Lymphoma
  • Therapy
  • World
  • Market Size

You can request one free hour of our analyst’s time when you purchase this market report.

  • Lymphoma
  • Therapy
  • World
  • Market Size
  • Tests for lymphoma
  • Diagnosis of lymphoma

HL is one of the curable forms of lymphoma.

  • Lymphoma
  • Forecast
  • Celgene Corporation
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

NHL: Follicular Lymphoma Forecast and Market Analysis (FL) to 2026 CONTENTS ## FORECAST: FOLLICULAR LYMPHOMA (Published on ## January 2019) ## OVERVIEW ## RECENT FORECAST UPDATES ## MARKET DYNAMICS ## FORECAST AND FUTURE TRENDS ## MARKET DEFINITION AND METHODOLOGY ## PRIMARY

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024 ##.

  • Cancer
  • Lymphoma
  • Therapy
  • World
  • Market Size

This cancer is the most common type of non-Hodgkin’s lymphoma (NHL), accounting for about one-third of all newly diagnosed cases.

  • Lymphoma
  • European Union
  • Japan
  • United States
  • Demand
  • CLASSIFICATION OF LYMPHOMAS
  • 2.3 CLASSIFICATION OF LYMPHOMA

FIGURE ##: DIFFERENT PROTEIN INTERACTION DOMAIN IN BTK Pleckstrin Homology (PH) TEC Homology (TH) SRC homology (SH) Kinase Source: Daedal Research Figure ##: Different Protein Interaction Domain in BTK Lymphomas are hematologic cancers involving lymphoceles of the immune sys

  • Lymphoma
  • World
  • AbbVie Inc.
  • AstraZeneca PLC
  • Johnson & Johnson

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025 TABLE OF CONTENTS Forecast, Treatment, Epidemiology Datapacks included) & nbsp; ## FORECAST: FOLLICULAR LYMPHOMA (Published on ## April 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVERVIEW AND TRENDS ## METHODOLOGY

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

The disease often initially responds to treatment, but disease relapse inevitably occurs within ##–## years.

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

This cancer is the most common type of non-Hodgkin’s lymphoma (NHL), accounting for about one-third of all newly diagnosed cases.

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

Pricing Details List of Figures FIGURE ##.

  • Lymphoma
  • United States
  • World
  • Market Size

This influence varies from one industry to another, but also from one period of time to another.

  • Cancer
  • Lymphoma
  • Therapy
  • World
  • Demand
  • MARKETED DRUG PROFILE: NIPPON SHINYAKU AND ROCHE'S GAZYVA
  • MARKETED DRUG PROFILE: ABBVIE AND JOHNSON & JOHNSON'S IMBRUVICA

TABLE OF CONTENTS ##.

  • Drug Development
  • Lymphoma
  • AbbVie Inc.
  • AstraZeneca PLC
  • Roche Group

There are various types of B-cell NHL including Burkitt lymphoma, chronic lymphocytic leukemia (CLL), follicular lymphoma, and mantle cell lymphoma.

  • Cancer
  • Lymphoma
  • Pathology
  • World
  • Germany
  • 6.1.4 CAR-T THERAPY IN DLBCL

The ranking system ranges from one (##) to five (##), with ## being the least favorable score and ## being the most favorable.

  • Cancer
  • Immunotherapy
  • Lymphoma
  • United States
  • Forecast

##.

  • Cancer
  • Lymphoma
  • World
  • Market Size

Betalutin

8770 10000 7800

Betalutin CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Betalutin : NHL: Follicular lymphoma (FL) LIST OF FIGURES ## Figure ##: Betalutin for follicular lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Betalutin for

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

Aliqopa

8770 10000 7800

Aliqopa CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Aliqopa : NHL: Follicular lymphoma (FL) LIST OF FIGURES ## Figure ##: Aliqopa for follicular lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Aliqopa for follicul

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

INCB050465

8770 10000 7800

INCB## CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## INCB## : NHL: Follicular lymphoma (FL) LIST OF FIGURES ## Figure ##: INCB## for follicular lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of INCB##

  • Cancer
  • Lymphoma
  • Pathology
  • United States
  • Forecast

umbralisib

8770 10000 7800

umbralisib CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## umbralisib : NHL: Follicular lymphoma (FL) ## umbralisib : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Umbralisib for follicular lymphoma – SWOT analysis ## Figure

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

lisocabtagene maraleucel CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## lisocabtagene maraleucel : NHL: Follicular lymphoma (FL) ## lisocabtagene maraleucel : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Lisocabtagene maraleucel for

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

Yescarta

8770 10000 7800

In heavily pretreated patients, Yescarta treatment resulted in strong and durable response rates, as demonstrated in the ZUMA-## trial.

  • Lymphoma
  • Medical Biotechnology
  • European Union
  • Japan
  • United States

Revlimid

8770 10000 7800

Revlimid CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Revlimid : NHL: Follicular lymphoma (FL) ## Revlimid : NHL: Diffuse large B-cell lymphoma (DLBCL) ## Revlimid : Multiple myeloma ## Revlimid : NHL: Mantle cell lymphoma (MCL) LIST OF FIGURES ## Figur

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States
  • Incidence.
  • 2 B-CELLNHL:EXECUTIVESUMMARY

In Japan, data on malignant lymphoma encompasses all type of lymphoma (CIS, NCC, 2018).

  • Cancer
  • Immunotherapy
  • Lymphoma
  • United States
  • Forecast

Kinenza

8770 10000 7800

Kinenza CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Kinenza : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: Kinenza for diffuse large B-cell lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary

  • Cancer
  • Lymphoma
  • Pathology
  • Therapy
  • United States

MOR208

8770 10000 7800

MOR## CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## MOR## : NHL: Diffuse large B-cell lymphoma (DLBCL) LIST OF FIGURES ## Figure ##: MOR## for diffuse large B-cell lymphoma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary for

  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • European Union
  • United States